We are live on ! Find out more
RS

R Squared Portfolio holdings

AUM $182M
1-Year Est. Return 18.52%
This Fund
S&P 500
This Quarter Est. Return
+0.5%
1 Year Est. Return
+18.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$214M
AUM Growth
-$18.4M
Cap. Flow
-$18M
Cap. Flow %
-8.42%
Top 10 Hldgs %
15.12%
Holding
759
New
222
Increased
150
Reduced
140
Closed
246

Top Buys

Rank Stock Value
1
BLK icon
Blackrock
BLK
+$3.58M
2
EA icon
Electronic Arts
EA
+$3.45M
3
MSI icon
Motorola Solutions
MSI
+$3.41M
4
FYBR
Frontier Communications
FYBR
+$2.34M
5
TSM icon
TSMC
TSM
+$2.33M

Top Sells

Rank Stock Value
1
HON icon
Honeywell
HON
+$2.7M
2
K
Kellanova
K
+$2.67M
3
KO icon
Coca-Cola
KO
+$2.47M
4
SCHW
Charles Schwab
SCHW
+$2.47M
5
ED icon
Consolidated Edison
ED
+$2.22M

Sector Composition

Rank Sector Weight
1 Financials 19.27%
2 Technology 18.98%
3 Industrials 15.12%
4 Healthcare 10.83%
5 Communication Services 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASST icon
501
Strive Inc
ASST
$1.06B
$15.9K 0.01%
+1,079
New +$25.8K
KOS icon
502
Kosmos Energy
KOS
$1.57B
$15.6K 0.01%
+17,195
New +$22.7K
YHC
503
LQR House Inc
YHC
$2.41M
$15.2K 0.01%
+169
New +$14.8K
NOTV
504
DELISTED
Inotiv
NOTV
$15K 0.01%
26,656
+12,379
+87% +$12.9K
GLDG
505
GoldMining Inc
GLDG
$186M
$13.9K 0.01%
+11,156
New +$15.6K
PRZO icon
506
ParaZero Technologies
PRZO
$13.3M
$12K 0.01%
+14,724
New +$20.3K
BRCC icon
507
BRC Inc
BRCC
$147M
$11.2K 0.01%
10,064
-246
-2% -$319
SKYE icon
508
Skye Bioscience
SKYE
$22.5M
$11.1K 0.01%
+14,782
New +$21.6K
FATE icon
509
Fate Therapeutics
FATE
$301M
$10.3K ﹤0.01%
10,458
-7,471
-42% -$8.97K
ATYR
510
aTyr Pharma
ATYR
$47.8M
$8.81K ﹤0.01%
+11,255
New +$9.24K
GAME icon
511
GameSquare
GAME
$42.8M
$6.87K ﹤0.01%
+17,841
New +$10.3K
CISO
512
CISO Global
CISO
$12.3M
$4.82K ﹤0.01%
+10,033
New +$8.21K
NAKA
513
Nakamoto Inc
NAKA
$84.7M
$3.52K ﹤0.01%
+250
New +$6.53K
ABBV icon
514
AbbVie
ABBV
$448B
-1,516
Closed -$351K
ACN icon
515
Accenture
ACN
$85.7B
-3,565
Closed -$879K
ADCT icon
516
ADC Therapeutics
ADCT
$158M
-14,714
Closed -$58.9K
ADP icon
517
Automatic Data Processing
ADP
$97.2B
-959
Closed -$281K
AES icon
518
AES
AES
$10.6B
-14,234
Closed -$187K
AGRO icon
519
Adecoagro
AGRO
$1.63B
-22,302
Closed -$175K
AIT icon
520
Applied Industrial Technologies
AIT
$12.6B
-3,482
Closed -$909K
ALE
521
DELISTED
Allete
ALE
-8,782
Closed -$583K
ALG icon
522
Alamo Group
ALG
$1.99B
-1,773
Closed -$338K
ALNY icon
523
Alnylam Pharmaceuticals
ALNY
$35.6B
-1,660
Closed -$757K
AMBP icon
524
Ardagh Metal Packaging
AMBP
$2.82B
-25,046
Closed -$99.9K
AME icon
525
Ametek
AME
$54.3B
-5,827
Closed -$1.1M

Similar funds

R Squared's Q4 2025 Portfolio in Review

As of Q4 2025, R Squared held 759 positions worth $214M, down 7.9% from $232M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

R Squared withdrew a net $18M in Q4 2025, closing 246 positions and reducing 140 holdings. Its most notable exit was Honeywell, an estimated $2.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.

Against the trend, R Squared opened a new position in Blackrock worth $3.51M.

  • R Squared's largest Q4 2025 buy was Blackrock: 3,276 shares worth $3.51M.
  • R Squared added most to Frontier Communications in Q4 2025, an estimated $2.34M increase.
  • R Squared's biggest Q4 2025 reduction was Charles Schwab, cutting an estimated $2.47M.
  • R Squared fully exited Honeywell in Q4 2025, selling an estimated $2.7M.
  • R Squared's ten largest holdings make up 15% of its $214M portfolio in Q4 2025.
  • R Squared opened 222 new positions and closed 246 in Q4 2025.
  • R Squared's portfolio value fell 7.9% quarter-over-quarter to $214M.

Based on R Squared's 13F filing for Q4 2025, filed 30 Jan 2026.